Mirtazapine for the Treatment of Depression and Nausea in Breast and Gynecological Oncology
- 1 July 2000
- journal article
- case report
- Published by Elsevier in Psychosomatics
- Vol. 41 (4) , 356-359
- https://doi.org/10.1176/appi.psy.41.4.356
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Strahlentherapie des alten patientenStrahlentherapie und Onkologie, 1999
- Prevalence of mood disorders and utility of the PRIME-MD in patients undergoing radiation therapyInternational Journal of Radiation Oncology*Biology*Physics, 1998
- Psychiatric disorders and gynecological oncology: a review of the literatureGeneral Hospital Psychiatry, 1998
- Mirtazapine, an antidepressantAmerican Journal of Health-System Pharmacy, 1998
- Antagonism of selective serotonin reuptake inhibitor-induced nausea by mirtazapineInternational Clinical Psychopharmacology, 1997
- Cancer and DepressionThe British Journal of Psychiatry, 1996
- Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer.Journal of Clinical Oncology, 1996
- Mirtazapine as Treatment for Serotonin SyndromePharmacopsychiatry, 1996
- Invited review: Psychological aspects of cancer and chemotherapyJournal of Psychosomatic Research, 1990
- Psychological impact of adjuvant chemotherapy in the first two years after mastectomy.BMJ, 1986